Genus plc (LON:GNS - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,822.91 ($23.20) and traded as high as GBX 1,862 ($23.70). Genus shares last traded at GBX 1,818.34 ($23.15), with a volume of 167,569 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Shore Capital reissued a "buy" rating on shares of Genus in a report on Wednesday, December 11th.
Read Our Latest Stock Analysis on GNS
Genus Trading Down 2.0 %
The firm has a market cap of £1.13 billion, a P/E ratio of 142.74, a P/E/G ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The firm has a fifty day moving average of GBX 1,862.04 and a 200-day moving average of GBX 1,819.49.
Genus (LON:GNS - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported GBX 39.80 ($0.51) earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. Equities research analysts forecast that Genus plc will post 70.9644323 earnings per share for the current year.
Insider Activity at Genus
In other news, insider Jorgen Kokke sold 19,967 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of GBX 1,731 ($22.03), for a total transaction of £345,628.77 ($439,955.16). 0.75% of the stock is currently owned by insiders.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Articles
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
